Cripto: A Target for Breast Cancer Treatment

doi 10.21236/ada418017
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Defense Technical Information Center

Related search

Estrogen Receptor-Beta Is a Potential Target for Triple Negative Breast Cancer Treatment

Oncotarget
Oncology
2018English

DDX3, a Potential Target for Cancer Treatment

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2015English

Mesothelin, a Novel Immunotherapy Target for Triple Negative Breast Cancer

Breast Cancer Research and Treatment
Cancer ResearchOncology
2012English

Lipocalin 2: A Potential Therapeutic Target for Breast Cancer Metastasis

OncoTargets and Therapy
OncologyPharmacology
2018English

EP4 as a Therapeutic Target for Aggressive Human Breast Cancer

2018English

Lewis Y Antigen as a Target for Breast Cancer Therapy

1996English

ICAM-1 as a Molecular Target for Triple Negative Breast Cancer

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2014English

Target Volume Definition and Target Conformal Irradiation Technique for Breast Cancer Patients

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
2000English

Mammaglobin as a Potential Molecular Target for Breast Cancer Drug Delivery

Cancer Cell International
Cancer ResearchOncologyGenetics
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy